The DOI matches its Crossref record.
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
Abstract
Nitric oxide (NO), which accounts for the biological properties of endothelium-derived relaxing factor, is generated by NO synthase (NOS). The vascular endothelium contains two types of NOS: one is constitutively expressed (cNOS), and the other is inducible. Endothelium-mediated vasorelaxation is impaired in atherosclerotic vessels. To determine whether tumor necrosis factor (TNF)-alpha, which is commonly found in atherosclerotic lesions, has an effect on NOS message, we measured cNOS mRNA levels in TNF-treated human umbilical vein endothelial cells (HUVECs) by RNA blot analysis with a cNOS cDNA probe. TNF-alpha markedly reduced cNOS mRNA levels in HUVECs in a dose- and time-dependent manner. In response to 3 ng/mL TNF-alpha, cNOS mRNA levels began to decrease at 4 hours and diminished to only 5% of control levels at 24 hours. As little as 0.1 ng/mL TNF-alpha reduced cNOS mRNA levels by 50%. This reduction in cNOS message in response to TNF-alpha depended on protein synthesis as it was blocked by cycloheximide. In nuclear runoff experiments, TNF-alpha did not change the rate of cNOS gene transcription. cNOS mRNA is very stable under basal conditions, with a half-life of 48 hours; however, treatment with TNF-alpha shortened this half-life to 3 hours. TNF-alpha thus appears to decrease cNOS mRNA levels by increasing the rate of mRNA degradation. TNF-induced reductions in cNOS mRNA levels may have an important effect on impaired endothelium-mediated vasorelaxation in atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“was shown to downregulate NOS3 expression and abundance [123, 131-134] by decreasing the stability of NOS3 mRNA [135, 136], effectively shortening its half-life [137].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [137]
Citations
Cited by
Sorted by citations
Items 401–500 of 775
Inflammation: A Link Between Hypertension and Atherosclerosis
Cachofeiro, V., Miana, M., Heras, N. D. L., Martín‐Fernández, B., Ballesteros, S., Balfagón, G., & Lahera, V. (2009) · Current Hypertension Reviews · doi:10.2174/157340209787314333 · Cited by 38
Liu, A. C., Lee, M. W., McManus, B. M., & Choy, J. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102527 · Cited by 36
Self-citationThe Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?
ŞAHİN, T. D., Utkan, T., Karson, A., Yazır, Y., Bayramgürler, D., & Gacar, N. (2014) · Inflammation · doi:10.1007/s10753-014-9867-4 · Cited by 36
“On the other hand, TNF-α is known to decrease eNOS expression [36] or increase NO inactivation [37], thus reducing NO availability.”
BackgroundChen, J., Zhang, J., Shaik, N. F., Yi, B., Wei, X., Yang, X., Naik, U. P., Summer, R. S., Yan, G., Xu, X., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011317 · Cited by 36
“Because many pathological conditions are known to decrease eNOS expression in endothelial cells by reducing mRNA stability (5, 6, 28, 29), identification of tubacin as a potent eNOS enhancer suggests that tubacin or its analogues might be effective in ameliorating systemic vascular complications of disease.”
BackgroundInterleukin-6 Correlates with Endothelial Dysfunction in Young Post-Myocardial Infarction Patients
Eržen, B., Šabović, M., Šebeštjen, M., Keber, I., & Poredoš, P. (2006) · Cardiology · doi:10.1159/000094588 · Cited by 39
Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction
Um, J., & Kim, H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.019 · Cited by 35
Keating, A. K., Freehauf, C. L., Jiang, H., Brodsky, G. L., Stabler, S. P., Allen, R. H., Graham, D. K., Thomas, J. A., Hove, J. L. K. V., & Maclean, K. N. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.04.012 · Cited by 33
Palma, C. D., Falcone, S., Panzeri, C., Radice, S., Bassi, M. T., & Clementi, E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05351.x · Cited by 35
“Indeed TNF-a affects eNOS expression in a timedependent way, by inducing first an increase and then a downregulation (Yoshizumi et al. 1993; Bove et al. 2001).”
BackgroundRole of Renal Cortical Neovascularization in Experimental Hypercholesterolemia
Chade, A., Krier, J. D., Galili, O., Lerman, A., & Lerman, L. O. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093989 · Cited by 35
Erkan, E., Devarajan, P., & Kaskel, F. J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33915 · Cited by 35
Lin, T., Fan, Y., Fan, K.-S., Juan, C., Chen, Y.-J., & Wu, C.-Y. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004591 · Cited by 38
“The upstream pathogenic cytokine of PsO, tumor necrosis factor-α (TNF-α), can trigger oxidative stress and augment angiotensin effects, resulting in endothelial damage and vasomotor disruption [6,7].”
Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-κB) and HOXA9
Trivedi, C. M., Patel, R. C., & Patel, C. V. (2007) · Gene · doi:10.1016/j.gene.2007.11.001 · Cited by 34
Evaluation of inflammatory mediators in the deciduas of pregnant women with pre-eclampsia/eclampsia
Peixoto, A. B., Júnior, E. A., Ribeiro, J. U., Rodrigues, D. B. R., Castro, E. C. C., Caldas, T. M. R. D. C., & Rodrigues, V. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.987117 · Cited by 34
“(eNOS) and induces apoptosis of trophoblast tissue [7,12].”
BackgroundChen, K., Inoue, M., Wasa, M., Fukuzawa, M., Kamata, S., & Okada, A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00677-2 · Cited by 34
Filep, J. G., Delalandre, A., & Beauchamp, M. (1997) · Circulation Research · doi:10.1161/01.res.81.5.840 · Cited by 34
Ain, Q. U., Chung, H., Chung, J. Y., Choi, J., & Kim, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.019 · Cited by 33
Yacoub, S., Lam, P. K., Huynh, T. T., Ho, H. H. N., Thi, H. T. D., Van, N. T., Lien, L. T., Ha, Q. N. T., Le, D. H. T., Mongkolspaya, J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix567 · Cited by 34
“We found no changes in levels of ADMA, making competitive inhibition of eNOS as a cause of the endothelial dysfunction less likely; however, the associated inflammatory response, specifically the inhibitory effect of TNF-α on eNOS, may play a role [28].”
BackgroundTumour necrosis factor α G−308A polymorphism and risk for coronary artery disease
Wang, X. L., & OOSTERHOF, J. (2000) · Clinical Science · doi:10.1042/cs0980435 · Cited by 35
FSH suppression of nitric oxide synthesis in porcine oocytes
Hattori, M., Nishida, N., TAKESUE, K., et al. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240065 · Cited by 33
“For example, tumor necrosis factor- is known to desensitize eNOS by controlling the fate of eNOS mRNA (Yoshizumi et al. 1993).”
BackgroundCharacterization of the murine endothelial nitric oxide synthase promoter
Teichert, A.-M., Karantzoulis-Fegaras, F., Wang, Y., Mawji, I. A., Bei, X., Gnanapandithen, K., & Marsden, P. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00236-x · Cited by 33
NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-α
de Frutos, T., de Miguel, L. S., Garcı́a-Durán, M., González-Fernández, F., Rodríguez-Feo, J. A., Montón, M., Guerra, J. I., Farré, J., Casado, S., & López-Farré, A. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.4.h1317 · Cited by 32
“It was also demonstrated that TNF-a decreases eNOS expression in endothelial cells (40).”
BackgroundInfluentialSánchez de Miguel, L., Alonso, J., González-Fernández, F., de la Osada, J., Montón, M., Rodríguez-Feo, J. A., Guerra, J. I., Arriero, M. M., Rico, L., Casado, S., et al. (1999) · Journal of Vascular Research · doi:10.1159/000025643 · Cited by 32
Li, W., Cui, N., Mazzuca, M. Q., Mata, K. M., & Khalil, R. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00207.2017 · Cited by 32
“TNF may also 506 downregulate eNOS (8, 96) and mitochondrial biogenesis, leading to mitochondrial 507 dysfunction, oxidative stress and increased ROS (81).”
BackgroundNajjar, R. S., Turner, C. G., Wong, B. J., & Feresin, R. G. (2021) · Nutrients · doi:10.3390/nu13020387 · Cited by 33
“TNF-α decreases eNOS mRNA in endothelial cells in a time-dependent manner [128], as well as eNOS protein expression [129], leading to reduced NO metabolite concentration.”
McCarty, M. F. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90217-1 · Cited by 32
Oberstraß, J., Reifenberger, G., REIFENBERGER, J., Wechsler, W., & Collins, V. P. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199606)179:2 · Cited by 76
MODULATION OF CORONARY VASOMOTOR TONE BY CYTOKINES IN CARDIAC TRANSPLANT RECIPIENTS
Weis, M., Wildhirt, S. M., Schulze, C. J., et al. (1999) · Transplantation · doi:10.1097/00007890-199911150-00008 · Cited by 32
The Nitric Oxide Pathway and Oxidative Stress in Heart Failure
Searles, C. D. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00715.x · Cited by 31
Effects of exercise training on the vascular reactivity of the whole kidney circulation in rabbits
de Moraes, R., Gioseffi, G., da Nóbrega, A. C. L., et al. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00923.2003 · Cited by 31
“Interestingly, it has been shown that TNF- induces a downregulation of eNOS, which results from a destabilization of eNOS mRNA with no effect on transcription (25, 60).”
BackgroundKajikawa, M., Nakashima, A., Maruhashi, T., Iwamoto, Y., Iwamoto, A., Matsumoto, T., Hidaka, T., Kihara, Y., Chayama, K., Goto, C., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1330 · Cited by 31
Rao, R., Sen, S., Han, B., Ramadoss, S., & Chaudhuri, G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1031-1_6 · Cited by 32
The Endothelial Cell Nitric Oxide Synthase: Is It Really Constitutively Expressed?
Harrison, D. G., Venema, R. C., Arnal, J., Inoue, N., Ohara, Y., Sayegh, H. S., & Murphy, T. J. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7346-8_16 · Cited by 32
Ruan, Z., Xie, X., Yu, H., Liu, R., Jing, W., & Lü, T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.930272 · Cited by 30
Proteasome inhibition prevents experimentally-induced endothelial dysfunction
Lorenz, M., Wilck, N., Meiners, S., et al. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.04.016 · Cited by 30
Christ, B., & Nath, A. (1996) · Biochemical Journal · doi:10.1042/bj3200161 · Cited by 30
Emerging concepts regarding pannexin 1 in the vasculature
Good, M. E., Begandt, D., DeLalio, L. J., Keller, A., Billaud, M., & Isakson, B. E. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150045 · Cited by 27
Small, H. Y., Nosalski, R., Morgan, H. L., Beattie, E. C., Guzik, T. J., Graham, D., & Delles, C. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07933 · Cited by 28
Verma, I., Syngle, A., & Krishan, P. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.10.013 · Cited by 29
“[96_TD$DIFF] The proinflammatory cytokine, TNF-a also degrades endothelial nitric oxide synthase (eNOS) mRNA and impaired NO bioavailability[97_TD$DIFF].(31,32) This impaired NO bioavailability is a primary manifestation of endothelial dysfunction, leading to impairment in EDV.”
BackgroundForoumandi, E., Alizadeh, M., Kheirouri, S., & Jafarabadi, M. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213307 · Cited by 29
Regulation of Nitric Oxide Synthase Expression and Activity
Förstermann, U. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57077-3_4 · Cited by 29
Marsen, T. A., Egink, G., Suckau, G., et al. (1999) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004249900079 · Cited by 29
Paracrine Role of the Endothelium in Metabolic Homeostasis in Health and Nutrient Excess
Luk, C., Haywood, N. J., Bridge, K., & Kearney, M. T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.882923 · Cited by 30
Expression of Endothelial Nitric Oxide Synthase in Human Peritoneal Tissue
Arriero, M., Rodríguez-Feo, J. A., Celdrán, Á., de Miguel, L. S., González-Fernández, F., Fortes, J., Reyero, A., Frieyro, O., de la Pinta, J. C., Franco, A., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11101848 · Cited by 28
Shin, C. S., Lecanda, F., Sheikh, S., Weitzmann, L., Cheng, S., & Civitelli, R. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000915)78:4 · Cited by 104
Major Depressive Disorder and Inflammatory Markers in Elderly Patients With Heart Failure
Andrei, A. M., Fráguas, R., Telles, R. M. S., Alves, T. C. T. F., Strunz, C. M. C., Nussbacher, A., Rays, J., Iosifescu, D. V., & Wajngarten, M. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.4.319 · Cited by 28
Laubach, V. E., Zhang, C. X., Russell, S. W., Murphy, W. J., & Sherman, P. A. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(96)06909-6 · Cited by 28
Weigert, A. L. L., Higa, E. M. S., Niederberger, M., et al. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122067 · Cited by 28
Ravichandran, L. V., & Johns, R. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01134-z · Cited by 28
Inflammation and endothelial dysfunction in rheumatoid arthritis.
González-Gay, M. Á., González‐Juanatey, C., & Martin, J. J. (2006) · PubMed · Cited by 28
Utkan, T., Yazır, Y., Karson, A., & Bayramgürler, D. (2015) · Current Neurovascular Research · doi:10.2174/1567202612666150311111340 · Cited by 27
“In endothelial cell cultures, TNF- decreases the expression of endothelial nitric oxide synthase (eNOS), which is the primary enzyme involved in NO production in the vasculature [23].”
BackgroundKataoka, H., Murakami, R., Numaguchi, Y., Okumura, K., & Murohara, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.025 · Cited by 27
Control and Consequences of Endothelial Nitric Oxide Formation
Fleming, I., & Busse, R. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61086-8 · Cited by 29
Sugamori, T., Ishibashi, Y., Shimada, T., Takahashi, N., Sakane, T., Ohata, S., Kunizawa, Y., Inoue, S., Nakamura, K., Ohta, Y., et al. (2002) · Circulation Journal · doi:10.1253/circj.66.627 · Cited by 27
Aleksandrowicz, M., Konop, M., Rybka, M., Mazurek, Ł., Stradczuk‐Mazurek, M., Kciuk, M., Bądzyńska, B., Dobrowolski, L., & Kuczeriszka, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136467 · Cited by 31
“Additionally, eNOS mRNA levels in endothelial cells are directly decreased by high TNF-α concentrations [22,23].”
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review
Naidoo, N., Moodley, J., & Naicker, T. (2021) · Hypertension Research · doi:10.1038/s41440-020-00604-y · Cited by 27
McCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1998.0758 · Cited by 27
Benhamou, Y., Miranda, S., Armengol, G., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.014 · Cited by 25
“This unreported effect may be in part the consequence of the elevated level of TNFα which is known to shorten the half-life of eNOS mRNA and to diminish the transcription rate of eNOS [22].”
BackgroundBayramgürler, D., Karson, A., Yazır, Y., Celikyurt, I. K., Kurnaz, S., & Utkan, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.007 · Cited by 27
“In endothelial cell culture, TNF-α decreases the expression of eNOS, which is the primary enzyme involved in NO production in the vasculature (Yoshizumi et al., 1993).”
BackgroundAntiobesogenic Role of Endothelial Nitric Oxide Synthase
Sansbury, B. E., & Hill, B. G. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800254-4.00013-1 · Cited by 26
Machalińska, A., Pius‐Sadowska, E., Babiak, K., et al. (2017) · Current Eye Research · doi:10.1080/02713683.2017.1358372 · Cited by 25
Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications
Adamopoulos, S. N., Parissis, J., & Kremastinos, D. T. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(02)00033-x · Cited by 25
Mitochondria As Potential Targets of Flavonoids: Focus on Adipocytes and Endothelial Cells
Duluc, L., Soleti, R., Clere, N., Andriantsitohaina, R., & Simard, G. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803251467 · Cited by 24
“Indeed, endothelial dysfunction, considered as the first step in the progression of vascular diseases, has been reported in obese patients and is induced by TNF through a down-regulation of endothelial nitric oxide (NO) synthase (eNOS) expression [11]; or by leptin, whose circulating levels are closely related to body…”
BackgroundBéguin, E. P., van den Eshof, B. L., Hoogendijk, A. J., Nota, B., Mertens, K., Meijer, A. B., & van den Biggelaar, M. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.08.011 · Cited by 24
Chen, Y., Stampley, J., Irving, B. A., & Dugas, T. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz203 · Cited by 22
Greenberg, S. S., Xie, J., Kolls, J. K., Nelson, S., Didier, P. J., & Mason, C. M. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01521.x · Cited by 24
C-reactive protein, inflammation and atherosclerosis: do we really understand it yet?
Weintraub, W. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2109 · Cited by 24
“European Heart Journal (2000) 21, 958–960 doi:10.1053/euhj.2000.2109, available online at http://www.idealibrary.com on”
BackgroundInfluentialEndothelial protective and antishock effects of a selective estrogen receptor modulator in rats
Ma, X. L., Gao, F., Chen, J., Christopher, T. A., Lopez, B. L., Ohlstein, E. H., & Yue, T. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h876 · Cited by 24
Raza, M. W., Essery, S. D., Weir, D. M., et al. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01310.x · Cited by 24
Tanazawa, T., Suzuki, Y., Anzai, M., et al. (1996) · Acta Neurochirurgica · doi:10.1007/bf01411745 · Cited by 24
Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions
Khatib-Massalha, E., & Méndez‐Ferrer, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.840044 · Cited by 26
“during inflammation, hypoxia or exposure to damaging stimuli (75, 76)], which is characterized by higher levels of reactive oxygen species (ROS) and apoptosis, impaired migration and angiogenesis , may contribute to the pathogenesis of aplastic anemias and contribute to graft failure after BM transplantation (77–79).”
BackgroundImmunogenetic biomarkers in inflammatory bowel diseases: Role of theIBD3region
Muro, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15037 · Cited by 23
Choi, S. K., Galán, M., Partyka, M., Trebak, M., Belmadani, S., & Matrougui, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.016 · Cited by 21
Weight Loss and Race Modulate Nitric Oxide Metabolism in Overweight Women
Fenster, C. P., Darley-Usmar, V. M., Landar, A. L., Gower, B. A., Weinsier, R. L., Hunter, G. R., & Patel, R. P. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.021 · Cited by 23
“For example, stimuli capable of downregulating eNOS expression and NO production include glucose, tumor necrosis factor a (TNF-a) [20], and high levels of oxidized low-density”
Background̈vesi, T. K., Royston, D., Yacoub, M. H., et al. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg114 · Cited by 23
The Role of Nitric Oxide in Heart Failure
Macdonald, P. S., Schyvens, C. G., & Winlaw, D. S. (1996) · Drugs & Aging · doi:10.2165/00002512-199608060-00007 · Cited by 23
Andrzejczak, D., Górska, D., & Czarnecka, E. (2006) · PubMed · Cited by 23
Schmid, F., Vudattu, N. K., Floerchinger, B., et al. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.01.029 · Cited by 22
“It has been reported that cytokine receptors of the tumornecrosis factor family regulate a number of stages of inflammation [14—16] especially endothelial cell activation [1,17,18].”
BackgroundGöçmez, S. S., Yazır, Y., Gacar, G., ŞAHİN, T. D., Arkan, S., Karson, A., & Utkan, T. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113019 · Cited by 22
Hu, S., Pi, Q., Xu, X., Yan, J., Guo, Y., Tan, W., He, A., Cheng, Z., Luo, S., & Xia, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118606 · Cited by 22
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes
Comini, L., Boraso, A., Bachetti, T., Bernocchi, P., Pasini, E., Bastianon, D., Curello, S., Terracciano, C. M., Ceconi, C., & Ferrari, R. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.11.001 · Cited by 22
Ali, M. I., Chen, X., & Didion, S. P. (2015) · Physiological Reports · doi:10.14814/phy2.12630 · Cited by 22
“Several stimuli are known to influence expression of eNOS (Balligand et al. 2009; Cosentino et al. 1997; Drummond et al. 2000; Saura et al. 2006; Srinivasan et al. 2004; Sun et al. 2012; Yoshizumi et al. 1993).”
BackgroundAsano, W., Takahashi, Y., Kawano, M., & Hantani, Y. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218812663 · Cited by 23
Nitric oxide synthases: regulation in disease
Wong, G. K. T., & Marsden, P. A. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.1.215 · Cited by 23
“TNF-a-mediated decrease in ecNOS mRNA content in endothelial cells is dependent on new protein synthesis as it can be blocked by cycloheximide [34].”
BackgroundSíndrome X cardiovascular y disfunción endotelial
Vázquez‐Rey, E., & Kaski, J. C. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76843-2 · Cited by 23
Hauck, W., Samlalsingh-Parker, J., Glibetić, M., et al. (1999) · Seminars in Perinatology · doi:10.1016/s0146-0005(99)80070-6 · Cited by 22
Bárbaro, G. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.06.006 · Cited by 22
“Vascular production of NO could lead to vasodilation but, conversely, TNF-a could also be down-regulating the isoform of iNOS in the endothelium, because TNF-a reduces the stability of endothelial NOS-RNA [30].”
BackgroundGonzález, A., & Valencia, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073632 · Cited by 22
“…of placental Furthermore, interleukins such as TNF-α and IL-6 lead to an increase in vascular permeability, and TNF-α can activate endothelial cells, decrease the amount of mRNA in nitric oxide synthase, and increase the production of endothelin-1, which is a potent vasoconstrictor [129–131].”
BackgroundMarczin, N. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.08.011 · Cited by 21
Pannella, M., Caliceti, C., Fortini, F., Aquila, G., Sega, F. V. D., Pannuti, A., Fortini, C., Morelli, M. B., Fucili, A., Francolini, G., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25373 · Cited by 22
“…are highly predictive of cardiovascular events in HF patients (Harutyunyan et al., 2013; Osmancik et al., 2013) and a large body of evidence suggests that this may be related to the induction of endothelial dysfunctions (Yoshizumi et al., 1993; Agnoletti et al., 1999a; Crook et al., 2002).”
Decreased frequency and duration of tooth brushing is a risk factor for endothelial dysfunction
Matsui, S., Kajikawa, M., Maruhashi, T., Iwamoto, Y., Iwamoto, A., Oda, N., Kishimoto, S., Hidaka, T., Kihara, Y., Chayama, K., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.049 · Cited by 20
Hiroi, Y., Noma, K., Kim, H.-H., Sladojević, N., Tabit, C. E., Li, Y., Soydan, G., Salomone, S., Moskowitz, M. A., & Liao, J. K. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-0732 · Cited by 21
Palatka, K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i11.1730 · Cited by 21
Nitric oxide and biopterin: a study in Chiaroscuro.
Nathan, C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117176 · Cited by 21
Lang, D. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00336-8 · Cited by 21
Drexler, H., Kurz, S. K., Jeserich, M., et al. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)90045-4 · Cited by 21
Zhao, J. H., Suyama, A., Chung, H., Fukuda, T., Tanaka, M., & Matsui, T. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.044 · Cited by 20
Suwannaprapha, P., Chaisri, U., Riyong, D., & Maneerat, Y. (2005) · Circulation Journal · doi:10.1253/circj.69.730 · Cited by 19
Zhang, Y., Li, H., Wang, M., Meng, G., Wang, Z., Deng, J., Wang, M., Zhang, Q., Yang, S., & Jiang, H. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9208949 · Cited by 20
“reported inhibiting eNOS expression could lead to endothelial dysfunction in human umbilical vein endothelial cells [34].”
Mokotedi, L. P., Millen, A. M. E., Mogane, C., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172786 · Cited by 20
Intapad, S., Saengsirisuwan, V., Prasannarong, M., et al. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf203173b · Cited by 20
Metadata
- Authors
- Yoshizumi, M., Perrella, M. A., Burnett, J. C., & Lee, M. E.
- Affiliations
- Harvard University (US)
- Venue
- Circulation Research
- Published
- 1993-07
- Volume
- 73
- Issue
- 1
- Pages
- 205-209
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2145570729
- Cited by
- 771
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 13 · 2021: 15 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 14 · 2016: 11 · 2015: 17 · 2014: 35 · 2013: 19 · 2012: 18
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- TNF-α, endothelial nitric oxide synthase, constitutive nitric oxide synthase, mRNA stability, mRNA degradation, human umbilical vein endothelial cells, atherosclerosis, cycloheximide, gene transcription
- MeSH terms
- Amino Acid Oxidoreductases, Base Sequence, Endothelium, Vascular, Half-Life, Humans, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Necrosis Factor-alpha, Umbilical Veins, Down-Regulation, Polymerase Chain Reaction, Nitric Oxide Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review